The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence (2025)

Lung cancer is one of the most prevalent and lethal cancers worldwide, with limited therapeutic options in advanced stages. Cannabinoids have recently attracted attention as potential anticancer agents; however, cannabidiol (CBD), a non-psychoactive compound derived from Cannabis sativa, has emerged